Peter Maag Insider Trading Activity
Every SEC Form 4 transaction reported by Peter Maag, sourced directly from SEC EDGAR and updated as new filings are accepted.
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Peter Maag buying or selling?
Peter Maag reported 1 open-market buys ($50.0K) and 55 sells ($47.9M) across 56 Form 4 filings at 2 companies — a net selling position of $47.9M.
Source: SEC EDGAR Form 4
What stands out
- Peter Maag has reported Form 4 transactions at 2 companies; the most active, CareDx, Inc. (CDNA), accounts for 55 of 56 filings (98%).
- The most recent Form 4 was accepted on Jul 10, 2025 (15 months ago).
- No open-market purchases or sales were reported in the last 12 months.
Key Statistics (as of Jul 10, 2025)
Insider sentiment
Net sellingNet insider flow of $47.9M in net selling, filed between Mar 28, 2018 – Jul 10, 2025.
Companies Peter Maag files for
Recent Peter Maag transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 10, 2025 | CDNA | Director | Sale | 10.0K | $185.8K | SEC ↗ |
| Jun 20, 2025 | CDNA | Director | Sale | 10.0K | $192.4K | SEC ↗ |
| May 2, 2025 | CDNA | Director | Sale | 13.3K | $228.8K | SEC ↗ |
| Dec 4, 2024 | CDNA | Director | Sale | 5.0K | $125.0K | SEC ↗ |
| Aug 22, 2024 | CDNA | Director | Sale | 35.6K | $1.2M | SEC ↗ |
| Jul 14, 2023 | CDNA | Director | Sale | 5.0K | $51.7K | SEC ↗ |
| Jun 29, 2023 | CDNA | Director | Sale | 2.4K | $21.2K | SEC ↗ |
| Mar 30, 2023 | MIRO | Director | Purchase | 31.3K | $50.0K | SEC ↗ |
| Feb 8, 2023 | CDNA | Director | Sale | 3.3K | $51.5K | SEC ↗ |
| Feb 4, 2023 | CDNA | Director | Sale | 5.0K | $85.8K | SEC ↗ |
| Aug 12, 2022 | CDNA | Director | Sale | 20.0K | $493.1K | SEC ↗ |
| Mar 8, 2022 | CDNA | Director | Sale | 10.0K | $328.1K | SEC ↗ |
| Feb 9, 2022 | CDNA | Director | Sale | 10.0K | $420.7K | SEC ↗ |
| Jan 6, 2022 | CDNA | Director | Sale | 10.0K | $444.5K | SEC ↗ |
| Dec 7, 2021 | CDNA | Director | Sale | 10.0K | $416.2K | SEC ↗ |
| Nov 9, 2021 | CDNA | Director | Sale | 10.0K | $494.0K | SEC ↗ |
| Oct 6, 2021 | CDNA | Executive Chair | Sale | 10.0K | $646.7K | SEC ↗ |
| Sep 8, 2021 | CDNA | Executive Chair | Sale | 10.0K | $736.8K | SEC ↗ |
| Aug 9, 2021 | CDNA | Executive Chair | Sale | 10.0K | $831.3K | SEC ↗ |
| Jul 7, 2021 | CDNA | Executive Chair | Sale | 10.0K | $907.0K | SEC ↗ |
| Jun 25, 2021 | CDNA | Executive Chair | Sale | 10.0K | $952.9K | SEC ↗ |
| Jun 11, 2021 | CDNA | Executive Chair | Sale | 2.5K | $227.0K | SEC ↗ |
| Jun 10, 2021 | CDNA | Executive Chair | Sale | 978 | $88.1K | SEC ↗ |
| Jun 8, 2021 | CDNA | Executive Chair | Sale | 26.5K | $2.3M | SEC ↗ |
| May 27, 2021 | CDNA | Executive Chair | Sale | 10.0K | $805.9K | SEC ↗ |
Showing the 25 most recent filings of 56. Screen every filing.
Peter Maag insider trading FAQ
Is Peter Maag buying or selling?
Across 56 SEC Form 4 filings, Peter Maag reported 1 open-market purchases totaling $50.0K and 55 sales totaling $47.9M — a net selling position of $47.9M.
Which companies does Peter Maag file Form 4s for?
Peter Maag has reported insider transactions at 2 companies, most often CareDx, Inc. (CDNA), Miromatrix Medical Inc. (MIRO).
How far back does Peter Maag's filing history go?
Trabud holds Peter Maag's SEC Form 4 filings from Mar 28, 2018 – Jul 10, 2025, sourced directly from SEC EDGAR.
Where does Trabud get Peter Maag's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Peter Maag and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener